Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture, Acupoint Injection, and Acupressure Massage for Motor and Swallowing Rehabilitation in Post-Acute Ischemic Stroke
NCT07846488Not yet recruiting
- Sponsor
- National Hospital of Acupuncture
- Start
- Dec 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Randomised trial of cerebrolysin in ischemic stroke, hemiplegia and neurogenic dysphagia (ND) (4 arms), sponsored by National Hospital of Acupuncture. Primary endpoint: Fugl-Meyer Assessment at 30 days. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic strokehemiplegianeurogenic dysphagia (ND)
Beyond the preview
Go deeper on NCT07846488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07846488.